Defense Advanced Research Projects AgencyTagged Content List

Prevention and Therapy

Biomedical technologies designed to thwart initial infection or injury, or enable faster healing afterward

Showing 42 results for Therapy RSS
04/13/2018
Dr. Tristan McClure-Begley joined DARPA as a Program Manager in October 2017. He came to DARPA from the University of Colorado, Boulder, where he was a Research Assistant Professor in the Department of Molecular, Cellular and Developmental Biology. His academic studies focused on molecular mechanisms of perturbations to complex biological systems, particularly drugs of abuse, toxins and neurodevelopmental disorders.
05/08/2013
For more than fifty years, researchers have been studying exactly how aspirin affects the human body. Despite thousands of publications on the topic, our understanding is still incomplete.
10/25/2013
Despite the best efforts of the Departments of Defense and Veterans Affairs to protect the health of U.S. servicemembers and veterans, the effects of neuropsychological illness brought on by war, traumatic injuries and other experiences are not always easily treated. While current approaches can often help to alleviate the worst effects of these illnesses, they are imprecise and not universally effective. Demand for new therapies is high as mental disorders are the leading cause of hospital bed days and the second leading cause of medical encounters for active duty servicemembers.1 Among veterans, ten percent of those receiving treatment from the Veterans’ Health Administration are provided mental health care or substance abuse counseling.2
03/05/2014
With an eye on the urgent need to develop breakthrough technologies for national security, the President’s requested budget of $2.915 billion in Fiscal Year (FY) 2015 for the Defense Advanced Research Projects Agency (DARPA) would allow the agency to pursue promising new ideas and help to restore some of the reductions in the agency’s budget from prior years.
05/27/2014
Work on DARPA’s Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) program is set to begin with teams led by UC San Francisco (UCSF), and Massachusetts General Hospital (MGH). The SUBNETS program seeks to reduce the severity of neuropsychological illness in service members and veterans by developing closed-loop therapies that incorporate recording and analysis of brain activity with near-real-time neural stimulation. The program, which will use next-generation devices inspired by current Deep Brain Stimulation (DBS) technology, was launched in support of President Obama’s brain initiative.